In the article “The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes”*, which was published in the current issue of Cell Metabolism, a research group comprised of scientists from the University Hospital in Tübingen, the Cancer Research Institute in Ontario, Canada, the Max Planck Institute of Biochemistry, Martinsried, Harvard…
Read more